Case Study: Drugs for Neglected Diseases Initiative achieves privacy-protected clinical trial data sharing with Privacy Analytics

DNDi anonymizes 18 studies in 3 months with Privacy Analytics

The Drugs for Neglected Diseases Initiative (DNDi) needed to share clinical trial data from 18 historical studies to advance research while protecting patient privacy. The challenge was complex due to small patient populations and varied data formats. DNDi partnered with Privacy Analytics to anonymize the data using their risk-based methodology.

Privacy Analytics implemented a robust anonymization process, grouping studies by disease and assessing re-identification risks. They anonymized all 18 studies within three months, a month ahead of schedule. This allowed DNDi to share the data confidently on a global platform, enabling further research and upholding their reputation for integrity while protecting participant privacy.

Drugs for Neglected Diseases Initiative (DNDi)